{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:40:01Z","timestamp":1793900401909,"version":"4.8.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T00:00:00Z","timestamp":1649635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T00:00:00Z","timestamp":1649635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001652","name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001652","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>In neonatal patients with necrotizing enterocolitis (NEC) the inflammatory response is mediated by a plurality of different proteins. The proteins olfactomedin 4 (OLFM4) and lysozyme (LYZ) are part of the intestinal mucosal defense and especially OLFM4 has rarely been evaluated in neonatal gastrointestinal diseases. The aim of this study was to analyze whether expression levels of both proteins of innate immunity, OLFM4 and lysozyme, were increased during NEC in neonates.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Intestinal tissues of patients with NEC were examined with immunohistochemical staining of formalin-fixed and paraffin-embedded sections of resected tissue using antibodies against OLFM4 and lysozyme. Staining-positive tissues were semi-quantitatively scored from 0 (no staining), 1 (weak staining), 2 (moderate staining) to 3 (highly intense staining) by two individual investigators. Intestinal tissue of infants with volvulus was used as a control as other intestinal tissue without major inflammation was not available.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Both applied antibodies against OLFM4 showed different staining patterns with higher staining intensity of the antibody OLFM4 (D1E4M). OLFM4 (median score of the antibody OLFM4 (D1E4M): 3.0) and lysozyme (median score: 3.0) are highly expressed in intestinal and immune cells during NEC. Expression of OLFM4 and lysozyme in the control samples with volvulus was observable but significantly lower (median score of the antibody OLFM4 (D1E4M): 1.25; median score of the antibody against LYZ: 2.0; <jats:italic>p<\/jats:italic>\u00a0=\u20090.033 and <jats:italic>p<\/jats:italic>\u00a0=\u20090.037, respectively).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Both proteins, OLFM4 and lysozyme, may play a role in the pathogenesis of NEC in neonatal patients, but the exact mechanisms of OLFM4 and lysozyme function and their role in immunological responses have not yet been resolved in detail. These observations add new insights as basis for further large-scale population research.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12887-022-03260-y","type":"journal-article","created":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T08:19:47Z","timestamp":1649665187000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Increased expression of OLFM4 and lysozyme during necrotizing enterocolitis in neonates: an observational research study"],"prefix":"10.1186","volume":"22","author":[{"given":"Sonja","family":"Diez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Renner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Bahlinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arndt","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Besend\u00f6rfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,11]]},"reference":[{"issue":"1","key":"3260_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1067\/j.cpsurg.2018.11.005","volume":"56","author":"J Knell","year":"2019","unstructured":"Knell J, Han SM, Jaksic T, Modi BP. Current status of necrotizing enterocolitis. Curr Probl Surg. 2019;56(1):11\u201338.","journal-title":"Curr Probl Surg"},{"key":"3260_CR2","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3389\/fped.2018.00312","volume":"6","author":"U Kessler","year":"2018","unstructured":"Kessler U, Hau EM, Kordasz M, Haefeli S, Tsai C, Klimek P, et al. Congenital heart disease increases mortality in neonates with necrotizing enterocolitis. Front Pediatr. 2018;6:312.","journal-title":"Front Pediatr"},{"issue":"5","key":"3260_CR3","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.pedneo.2017.11.018","volume":"59","author":"A Bein","year":"2018","unstructured":"Bein A, Eventov-Friedman S, Arbell D, Schwartz B. Intestinal tight junctions are severely altered in NEC preterm neonates. Pediatr Neonatol. 2018;59(5):464\u201373.","journal-title":"Pediatr Neonatol"},{"issue":"2","key":"3260_CR4","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00418-015-1381-8","volume":"145","author":"H Muller","year":"2016","unstructured":"Muller H, Renner M, Helmke BM, Mollenhauer J, Felderhoff-Muser U. Elevated DMBT1 levels in neonatal gastrointestinal diseases. Histochem Cell Biol. 2016;145(2):227\u201337.","journal-title":"Histochem Cell Biol"},{"issue":"17","key":"3260_CR5","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.3748\/wjg.v24.i17.1881","volume":"24","author":"XY Wang","year":"2018","unstructured":"Wang XY, Chen SH, Zhang YN, Xu CF. Olfactomedin-4 in digestive diseases: a mini-review. World J Gastroenterol. 2018;24(17):1881\u20137.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"3260_CR6","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1189\/jlb.0811417","volume":"91","author":"SN Clemmensen","year":"2012","unstructured":"Clemmensen SN, Bohr CT, R\u00f8rvig S, Glenth\u00f8j A, Mora-Jensen H, Cramer EP, et al. Olfactomedin 4 defines a subset of human neutrophils. J Leukoc Biol. 2012;91(3):495\u2013500.","journal-title":"J Leukoc Biol"},{"issue":"4","key":"3260_CR7","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.crohns.2011.09.013","volume":"6","author":"M Gersemann","year":"2012","unstructured":"Gersemann M, Becker S, Nuding S, Antoni L, Ott G, Fritz P, et al. Olfactomedin-4 is a glycoprotein secreted into mucus in active IBD. J Crohns Colitis. 2012;6(4):425\u201334.","journal-title":"J Crohns Colitis"},{"issue":"2","key":"3260_CR8","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10555-016-9624-2","volume":"35","author":"W Liu","year":"2016","unstructured":"Liu W, Rodgers GP. Olfactomedin 4 expression and functions in innate immunity, inflammation, and cancer. Cancer Metastasis Rev. 2016;35(2):201\u201312.","journal-title":"Cancer Metastasis Rev"},{"issue":"40","key":"3260_CR9","doi-asserted-by":"publisher","first-page":"5237","DOI":"10.1038\/onc.2016.58","volume":"35","author":"W Liu","year":"2016","unstructured":"Liu W, Li H, Hong SH, Piszczek GP, Chen W, Rodgers GP. Olfactomedin 4 deletion induces colon adenocarcinoma in Apc(Min\/+) mice. Oncogene. 2016;35(40):5237\u201347.","journal-title":"Oncogene"},{"issue":"5","key":"3260_CR10","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1136\/gut.48.5.623","volume":"48","author":"S Shinozaki","year":"2001","unstructured":"Shinozaki S, Nakamura T, Iimura M, Kato Y, Iizuka B, Kobayashi M, et al. Upregulation of Reg 1alpha and GW112 in the epithelium of inflamed colonic mucosa. Gut. 2001;48(5):623\u20139.","journal-title":"Gut"},{"key":"3260_CR11","first-page":"100906","volume":"25","author":"R Kuno","year":"2021","unstructured":"Kuno R, Ito G, Kawamoto A, Hiraguri Y, Sugihara HY, Takeoka S, et al. Notch and TNF-\u03b1 signaling promote cytoplasmic accumulation of OLFM4 in intestinal epithelium cells and exhibit a cell protective role in the inflamed mucosa of IBD patients. Biochem Biophys Rep. 2021;25:100906.","journal-title":"Biochem Biophys Rep"},{"issue":"1","key":"3260_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1053\/j.gastro.2009.05.035","volume":"137","author":"LG van der Flier","year":"2009","unstructured":"van der Flier LG, Haegebarth A, Stange DE, van de Wetering M, Clevers H. OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cells. Gastroenterology. 2009;137(1):15\u20137.","journal-title":"Gastroenterology"},{"issue":"7","key":"3260_CR13","doi-asserted-by":"publisher","first-page":"e0131927","DOI":"10.1371\/journal.pone.0131927","volume":"10","author":"HK Brand","year":"2015","unstructured":"Brand HK, Ahout IML, de Ridder D, van Diepen A, Li Y, Zaalberg M, et al. Olfactomedin 4 serves as a marker for disease severity in pediatric respiratory syncytial virus (RSV) infection. PLoS One. 2015;10(7):e0131927.","journal-title":"PLoS One"},{"issue":"4","key":"3260_CR14","doi-asserted-by":"publisher","first-page":"e426","DOI":"10.1097\/CCM.0000000000002102","volume":"45","author":"MN Alder","year":"2017","unstructured":"Alder MN, Opoka AM, Lahni P, Hildeman DA, Wong HR. Olfactomedin-4 is a candidate marker for a pathogenic neutrophil subset in septic shock. Crit Care Med. 2017;45(4):e426\u201332.","journal-title":"Crit Care Med"},{"issue":"3","key":"3260_CR15","doi-asserted-by":"publisher","first-page":"F809","DOI":"10.1152\/ajprenal.00443.2019","volume":"318","author":"JE Stark","year":"2020","unstructured":"Stark JE, Opoka AM, Mallela J, Devarajan P, Ma Q, Levinsky NC, et al. Juvenile OLFM4-null mice are protected from sepsis. Am J Physiol Renal Physiol. 2020;318(3):F809\u201316.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"9","key":"3260_CR16","doi-asserted-by":"publisher","first-page":"e1006512","DOI":"10.1371\/journal.ppat.1006512","volume":"13","author":"SA Ragland","year":"2017","unstructured":"Ragland SA, Criss AK. From bacterial killing to immune modulation: recent insights into the functions of lysozyme. PLoS Pathog. 2017;13(9):e1006512.","journal-title":"PLoS Pathog"},{"issue":"Pt 2","key":"3260_CR17","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1042\/bj20031810","volume":"380","author":"P Markart","year":"2004","unstructured":"Markart P, Faust N, Graf T, Na CL, Weaver TE, Akinbi HT. Comparison of the microbicidal and muramidase activities of mouse lysozyme M and P. Biochem J. 2004;380(Pt 2):385\u201392.","journal-title":"Biochem J"},{"key":"3260_CR18","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1017\/erm.2016.13","volume":"18","author":"SX Cho","year":"2016","unstructured":"Cho SX, Berger PJ, Nold-Petry CA, Nold MF. The immunological landscape in necrotising enterocolitis. Expert Rev Mol Med. 2016;18:e12.","journal-title":"Expert Rev Mol Med"},{"key":"3260_CR19","doi-asserted-by":"publisher","first-page":"899","DOI":"10.3389\/fimmu.2020.00899","volume":"11","author":"MES Sampah","year":"2020","unstructured":"Sampah MES, Hackam DJ. Dysregulated mucosal immunity and associated pathogeneses in preterm neonates. Front Immunol. 2020;11:899.","journal-title":"Front Immunol"},{"issue":"3","key":"3260_CR20","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jpedsurg.2018.06.012","volume":"54","author":"DJ Hackam","year":"2019","unstructured":"Hackam DJ, Sodhi CP, Good M. New insights into necrotizing enterocolitis: from laboratory observation to personalized prevention and treatment. J Pediatr Surg. 2019;54(3):398\u2013404.","journal-title":"J Pediatr Surg"},{"issue":"12","key":"3260_CR21","doi-asserted-by":"publisher","first-page":"13660","DOI":"10.1096\/fj.201901231R","volume":"33","author":"NC Levinsky","year":"2019","unstructured":"Levinsky NC, Mallela J, Opoka AM, Harmon K, Lewis HV, Zingarelli B, et al. The olfactomedin-4 positive neutrophil has a role in murine intestinal ischemia\/reperfusion injury. FASEB J. 2019;33(12):13660\u20138.","journal-title":"FASEB J"},{"issue":"7","key":"3260_CR22","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1136\/jcp.51.7.512","volume":"51","author":"HB Coutinho","year":"1998","unstructured":"Coutinho HB, da Mota HC, Coutinho VB, Robalinho TI, Furtado AF, Walker E, et al. Absence of lysozyme (muramidase) in the intestinal Paneth cells of newborn infants with necrotising enterocolitis. J Clin Pathol. 1998;51(7):512\u20134.","journal-title":"J Clin Pathol"},{"issue":"4","key":"3260_CR23","doi-asserted-by":"publisher","first-page":"G656","DOI":"10.1152\/ajpgi.00550.2010","volume":"301","author":"SJ McElroy","year":"2011","unstructured":"McElroy SJ, Prince LS, Weitkamp J-H, Reese J, Slaughter JC, Polk DB. Tumor necrosis factor receptor 1-dependent depletion of mucus in immature small intestine: a potential role in neonatal necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol. 2011;301(4):G656\u201366.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"3260_CR24","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3389\/fimmu.2020.00587","volume":"11","author":"SR Lueschow","year":"2020","unstructured":"Lueschow SR, McElroy SJ. The Paneth cell: the curator and defender of the immature small intestine. Front Immunol. 2020;11:587.","journal-title":"Front Immunol"},{"issue":"4","key":"3260_CR25","first-page":"522","volume":"5","author":"C Zhang","year":"2012","unstructured":"Zhang C, Sherman MP, Prince LS, Bader D, Weitkamp JH, Slaughter JC, et al. Paneth cell ablation in the presence of Klebsiella pneumoniae induces necrotizing enterocolitis (NEC)-like injury in the small intestine of immature mice. Dis Model Mech. 2012;5(4):522\u201332.","journal-title":"Dis Model Mech"},{"key":"3260_CR26","doi-asserted-by":"publisher","first-page":"7345426","DOI":"10.1155\/2018\/7345426","volume":"2018","author":"L Markasz","year":"2018","unstructured":"Markasz L, Wanders A, Szekely L, Lilja HE. Diminished DEFA6 expression in Paneth cells is associated with necrotizing enterocolitis. Gastroenterol Res Pract. 2018;2018:7345426.","journal-title":"Gastroenterol Res Pract"},{"issue":"1","key":"3260_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/MPG.0b013e318186d341","volume":"49","author":"MW Schaart","year":"2009","unstructured":"Schaart MW, de Bruijn AC, Bouwman DM, de Krijger RR, van Goudoever JB, Tibboel D, et al. Epithelial functions of the residual bowel after surgery for necrotising enterocolitis in human infants. J Pediatr Gastroenterol Nutr. 2009;49(1):31\u201341.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"3260_CR28","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1203\/PDR.0b013e3182092a9a","volume":"69","author":"PJ Puiman","year":"2011","unstructured":"Puiman PJ, Burger-van Paassen N, Schaart MW, de Bruijn ACJM, de Krijger RR, Tibboel D, et al. Paneth cell hyperplasia and metaplasia in necrotizing enterocolitis. Pediatr Res. 2011;69(3):217\u201323.","journal-title":"Pediatr Res"},{"issue":"1","key":"3260_CR29","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1203\/00006450-199807000-00003","volume":"44","author":"NH Salzman","year":"1998","unstructured":"Salzman NH, Polin RA, Harris MC, Ruchelli E, Hebra A, Zirin-Butler S, et al. Enteric defensin expression in necrotizing enterocolitis. Pediatr Res. 1998;44(1):20\u20136.","journal-title":"Pediatr Res"},{"issue":"5","key":"3260_CR30","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/pr.2012.11","volume":"71","author":"MA Underwood","year":"2012","unstructured":"Underwood MA, Kananurak A, Coursodon CF, Adkins-Reick CK, Chu H, Bennett SH, et al. Bifidobacterium bifidum in a rat model of necrotizing enterocolitis: antimicrobial peptide and protein responses. Pediatr Res. 2012;71(5):546\u201351.","journal-title":"Pediatr Res"},{"issue":"1","key":"3260_CR31","doi-asserted-by":"publisher","first-page":"6692","DOI":"10.1038\/s41598-020-63593-5","volume":"10","author":"JY Lock","year":"2020","unstructured":"Lock JY, Carlson TL, Yu Y, Lu J, Claud EC, Carrier RL. Impact of developmental age, necrotizing enterocolitis associated stress, and oral therapeutic intervention on mucus barrier properties. Sci Rep. 2020;10(1):6692.","journal-title":"Sci Rep"},{"issue":"3","key":"3260_CR32","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.ajpath.2018.11.015","volume":"189","author":"E Managlia","year":"2019","unstructured":"Managlia E, Liu SXL, Yan X, Tan XD, Chou PM, Barrett TA, et al. Blocking NF-\u03baB activation in Ly6c(+) monocytes attenuates necrotizing enterocolitis. Am J Pathol. 2019;189(3):604\u201318.","journal-title":"Am J Pathol"},{"issue":"1","key":"3260_CR33","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1093\/ibd\/izx011","volume":"24","author":"M Di Ruscio","year":"2017","unstructured":"Di Ruscio M, Vernia F, Ciccone A, Frieri G, Latella G. Surrogate fecal biomarkers in inflammatory bowel disease: rivals or complementary tools of fecal calprotectin? Inflamm Bowel Dis. 2017;24(1):78\u201392.","journal-title":"Inflamm Bowel Dis"},{"issue":"12","key":"3260_CR34","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.3390\/antibiotics10121534","volume":"10","author":"P Ferraboschi","year":"2021","unstructured":"Ferraboschi P, Ciceri S, Grisenti P. Applications of lysozyme, an innate immune defense factor, as an alternative antibiotic. Antibiotics. 2021;10(12):1534.","journal-title":"Antibiotics"},{"key":"3260_CR35","doi-asserted-by":"publisher","first-page":"767642","DOI":"10.3389\/fphar.2021.767642","volume":"12","author":"L Jiang","year":"2021","unstructured":"Jiang L, Li Y, Wang L, Guo J, Liu W, Meng G, et al. Recent insights into the prognostic and therapeutic applications of lysozymes. Front Pharmacol. 2021;12:767642.","journal-title":"Front Pharmacol"},{"issue":"1","key":"3260_CR36","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1186\/s13063-017-2278-8","volume":"18","author":"WD Cheng","year":"2017","unstructured":"Cheng WD, Wold KJ, Benzoni NS, Thakwalakwa C, Maleta KM, Manary MJ, et al. Lactoferrin and lysozyme to reduce environmental enteric dysfunction and stunting in Malawian children: study protocol for a randomized controlled trial. Trials. 2017;18(1):523.","journal-title":"Trials"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-022-03260-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-022-03260-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-022-03260-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T08:20:08Z","timestamp":1649665208000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-022-03260-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,11]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3260"],"URL":"https:\/\/doi.org\/10.1186\/s12887-022-03260-y","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,11]]},"assertion":[{"value":"14 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the local ethical committees (ethics committee of the medical faculty of the Ruprecht-Karls-Universit\u00e4t of Heidelberg, Germany; ethics committee of the medical faculty of the Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg, Germany) and was performed in line with the principles of the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Due to the retrospective analysis of anonymized data without further patient contact, both, the ethics committee of the medical faculty of the Ruprecht-Karls-Universit\u00e4t of Heidelberg and the ethics committee of the medical faculty of the Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg approved informed consent waiver.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"192"}}